Nuove strategie antipiastriniche.

Translated title of the contribution: New anti-platelet strategies

Research output: Contribution to journalArticle

Abstract

In the 1960s, the platelet inhibitory properties of several drugs were discovered. Like aspirin, they were already in clinical use for other therapeutic indications. Since then, the search for new and more rational antiplatelet strategies has been constant but only moderately successful, although new molecules with high selectivity for platelet function have been developed. The authors briefly review some recent advances in platelet pharmacology and focus their attention on pharmacogenetics, a potential approach to new antiplatelet strategies. Would this approach be successful, individuals rather than epidemiologically defined groups of patients might better benefit from newly targeted antiplatelet drugs.

Original languageItalian
Pages (from-to)7-9
Number of pages3
JournalItalian Heart Journal
Volume2
Issue number1 Suppl
Publication statusPublished - Jan 2001

Fingerprint

Blood Platelets
Pharmacogenetics
Platelet Aggregation Inhibitors
Therapeutic Uses
Aspirin
Pharmacology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Nuove strategie antipiastriniche. / de Gaetano, G.; Cerletti, C.

In: Italian Heart Journal, Vol. 2, No. 1 Suppl, 01.2001, p. 7-9.

Research output: Contribution to journalArticle

@article{5a49523eeece449fa3cd4e91c0e41ac1,
title = "Nuove strategie antipiastriniche.",
abstract = "In the 1960s, the platelet inhibitory properties of several drugs were discovered. Like aspirin, they were already in clinical use for other therapeutic indications. Since then, the search for new and more rational antiplatelet strategies has been constant but only moderately successful, although new molecules with high selectivity for platelet function have been developed. The authors briefly review some recent advances in platelet pharmacology and focus their attention on pharmacogenetics, a potential approach to new antiplatelet strategies. Would this approach be successful, individuals rather than epidemiologically defined groups of patients might better benefit from newly targeted antiplatelet drugs.",
author = "{de Gaetano}, G. and C. Cerletti",
year = "2001",
month = "1",
language = "Italian",
volume = "2",
pages = "7--9",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",
number = "1 Suppl",

}

TY - JOUR

T1 - Nuove strategie antipiastriniche.

AU - de Gaetano, G.

AU - Cerletti, C.

PY - 2001/1

Y1 - 2001/1

N2 - In the 1960s, the platelet inhibitory properties of several drugs were discovered. Like aspirin, they were already in clinical use for other therapeutic indications. Since then, the search for new and more rational antiplatelet strategies has been constant but only moderately successful, although new molecules with high selectivity for platelet function have been developed. The authors briefly review some recent advances in platelet pharmacology and focus their attention on pharmacogenetics, a potential approach to new antiplatelet strategies. Would this approach be successful, individuals rather than epidemiologically defined groups of patients might better benefit from newly targeted antiplatelet drugs.

AB - In the 1960s, the platelet inhibitory properties of several drugs were discovered. Like aspirin, they were already in clinical use for other therapeutic indications. Since then, the search for new and more rational antiplatelet strategies has been constant but only moderately successful, although new molecules with high selectivity for platelet function have been developed. The authors briefly review some recent advances in platelet pharmacology and focus their attention on pharmacogenetics, a potential approach to new antiplatelet strategies. Would this approach be successful, individuals rather than epidemiologically defined groups of patients might better benefit from newly targeted antiplatelet drugs.

UR - http://www.scopus.com/inward/record.url?scp=0035221627&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035221627&partnerID=8YFLogxK

M3 - Articolo

C2 - 11216085

VL - 2

SP - 7

EP - 9

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

IS - 1 Suppl

ER -